NYSE:INGRFood
Ingredion (INGR) Agreed A $3.6 Billion Transformative Ingredients Deal
Ingredion (NYSE:INGR) has agreed to acquire Tate & Lyle in a cash-and-stock deal valued at about US$3.6b.
The transaction targets Tate & Lyle's expertise in texture and health-focused ingredients for food and beverage reformulation.
Management plans to reshape Ingredion's portfolio toward solutions that help brands adjust recipes for health and taste demands.
The Tate & Lyle acquisition is only one piece of the wider Ingredion story that long term investors may want to study further. Our...